ABSTRACT
Neoadjuvant therapy has been one of the standard therapies for borderline resectable pancreatic cancer and locally advanced pancreatic cancer, but it may deteriorate these patients' nutritional status while controlling the progress of cancer, which inevitably influences these patients' postoperative outcomes and prognosis.In this article, we tried to answer this problem by reviewing other studies.And we found that neoadjuvant therapy would influence patients' postoperative outcomes and prognosis by deteriorating their nutritional status.But effective nutritional support can prevent it.It indicates that there is a need for these patients to receive nutritional support as soon as possible.However, in consideration of the limited number of relevant studies and their limitations, there is a need for more studies with strict design to answer this problem.And it can provide evidence for early nutritional support in pancreatic cancer patients who is going to undergo neoadjuvant therapy.
Subject(s)
Neoadjuvant Therapy , Nutritional Status , Nutritional Support , Pancreatic Neoplasms , Humans , Pancreatic Neoplasms/therapy , Postoperative Period , Preoperative Care , PrognosisABSTRACT
Objective: To investigate the therapeutic effect of Jin Long Capsule (JLC) combined with neoadjuvant chemotherapy on the invasive breast cancer, and to explore the mechanism of JLC in inhibiting multidrug resistance of breast cancer. Methods: 200 patients were divided into experimental group and control group (100 cases per group). The control group used TEC regimen for neoadjuvant chemotherapy. And the experimental group was treated with TEC regimen combined with oral JLC. According to the Miller & Payne grading system (MP), the efficacy of neoadjuvant chemotherapy was evaluated based on histopathological changes of breast cancer after neoadjuvant chemotherapy. Adverse effect was evaluated according to the classification criteria of the National Cancer Institute of the United States-The Common Terminology Criteria for Adverse Events (CTCAE) version 3.0. The expression of P-glycoprotein (P-gp), glutathione thiol transferase (GST)-π and topoisomerase â ¡α (Topoâ ¡α) in breast cancer tissues before and after neoadjuvant chemotherapy were detected by immunohistochemical staining. Results: There were 83 effective cases (83%) in the experimental group, which was higher than that in the control group (65.0%, P<0.05). The incidence of leukopenia, gastrointestinal reactions and alopecia in grade 3 to 4 of the experimental group were lower than those of the control group (all P<0.05). The positive rates of P-gp, GST-π and Topoâ ¡α expression in the control group were 65.0% (65/100), 61.0% (61/100) and 69.0% (69/100), respectively, and they were 80.6% (75/93), 78.5% (73/93) and 37.6% (35/93) after chemotherapy. The positive rates of P-gp and GST-π expression were significantly higher than those before chemotherapy (both P<0.05), whereas the positive rate of Topoâ ¡α expression was significantly lower than that before chemotherapy (P<0.05). In the experimental group, the positive rates of P-gp, GST-π and Topoâ ¡α expression before chemotherapy were 62.0% (62/100), 63.0% (63/100) and 69.0% (69/100), respectively, while after chemotherapy, they were 68.2% (60/88), 67.0% (59/88) and 63.6% (56/88). There was no significant difference in the positive rates and expression intensity of P-gp, GST-π and Topoâ ¡α before and after the chemotherapy (P>0.05). Conclusion: Jin Long Capsule (JLC) can inhibit multidrug resistance, improve the efficacy of neoadjuvant chemotherapy, and reduce adverse reactions of breast cancer.
Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Drug Resistance, Neoplasm , Drugs, Chinese Herbal/therapeutic use , Neoadjuvant Therapy , ATP Binding Cassette Transporter, Subfamily B , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Breast Neoplasms/pathology , Capsules , Chemotherapy, Adjuvant/adverse effects , Cyclophosphamide/administration & dosage , Cyclophosphamide/adverse effects , DNA Topoisomerases, Type II/metabolism , Etoposide/administration & dosage , Etoposide/adverse effects , Female , Glutathione Transferase/metabolism , Humans , Neoadjuvant Therapy/adverse effects , Taxoids/administration & dosage , Taxoids/adverse effectsABSTRACT
The factors influencing the evaluation of the quality of Peucedanum praeruptorum Dunn, called "Qianhu" in Chinese, include the botanical origin, places of production, harvesting time and its nature of "Ci Xiong" (bolting and unbolting) etc. The orthodox products are derived from Peucedanum praeruptorum Dunn in successive dynasties, especially the unbolting one produced in Anhui and Zhejiang Provinces picked up during the Beginning of Winter. The "assessment of quality based on its features" includes the "Earthworm head" , "black skin of the root" , "gold inlaid with white jade" , "soft texture like sweet rice" and "strong fragrant smell" . Therefore, the "assessment of quality based on its features" is the summary of all its properties, including the morphology, color, flavor, and property, and it's also the background for evaluating its quality and embodying the wisdom of distinguishing experiences of ancient herbologists.
ABSTRACT
Objective: To investigate the association between tea consumption and lung cancer risk in Chinese males. Methods: Tea consumption and incident lung cancer cases were collected on a biennial basis among males in Kailuan Cohort during 2006-2015. Up to 31st December 2015, a total of 103 010 male candidates from the Chinese Kailuan Male Cohort Study were enrolled in the present study. Cox proportional hazards regression model was used to evaluate the association between tea consumption and risk of lung cancer in males. Results: The age of male candidates was (51.3±13.4)years old. There were 828 810.74 person-years of follow-up and 8.91 years of median follow-up period. During the follow-up, 964 lung cancer cases were identified. In male, the rate of never cosumers, tea drinkers (<4/week) and tea drinkers (≥4/week) were 58.17%(n=59 926), 24.04%(n=24 765) and 17.78%(n=18 319), respectively. After adjustment for potential confounding factors, HR (95%CI) of lung cancer for subjects with tea drinkers (<4/week) and tea drinkers (≥4/week) were 0.80 (0.63-1.02) and 1.02 (0.80-1.30), respectively, as compared with never cosumers. The results showed no significant association with lung cancer. Stratification analysis and sensitivity analysis showed no significant changes. Conclusion: Our study has not found that tea consumption is significantly associated with the risk of male lung cancer.
Subject(s)
Lung Neoplasms/epidemiology , Adult , China/epidemiology , Cohort Studies , Female , Humans , Male , Middle Aged , Proportional Hazards Models , Prospective Studies , Risk , Risk Factors , TeaABSTRACT
BACKGROUND: No analytic epidemiological study has examined the relationship between use of muscle-building supplements (MBSs) and testicular germ cell cancer (TGCC) risk. METHODS: We conducted a population-based case-control study including 356 TGCC cases and 513 controls from Connecticut and Massachusetts. RESULTS: The odds ratio (OR) for ever use of MBSs in relation to risk of TGCC was significantly elevated (OR=1.65, 95% confidence interval (CI): 1.11-2.46). The associations were significantly stronger among early users, men with more types of MBSs used, and longer periods of use. CONCLUSIONS: MBS use is a potentially modifiable risk factor that may be associated with TGCC.
Subject(s)
Dietary Supplements/statistics & numerical data , Muscle Strength/drug effects , Neoplasms, Germ Cell and Embryonal/epidemiology , Testicular Neoplasms/epidemiology , Adult , Case-Control Studies , Connecticut/epidemiology , Dietary Supplements/adverse effects , Humans , Male , Massachusetts/epidemiology , Risk FactorsABSTRACT
BACKGROUND: In rodents, hypothalamic brain-derived neurotrophic factor (BDNF) expression appears to be regulated by melanocortin-4 receptor (MC4R) activity. The impact of MC4R genetic variation on circulating BDNF in humans is unknown. OBJECTIVE: The objective of this study is to compare BDNF concentrations of subjects with loss-of-function (LOF) and gain-of-function (GOF) MC4R variants with those of controls with common sequence MC4R. METHODS: Circulating BDNF was measured in two cohorts with known MC4R sequence: 148 subjects of Pima Indian heritage ((mean±s.d.): age, 15.7±6.5 years; body mass index z-scores (BMI-Z), 1.63±1.03) and 69 subjects of Hispanic heritage (10.8±3.6 years; BMI-Z, 1.57±1.07). MC4R variants were characterized in vitro by cell surface expression, receptor binding and cyclic AMP response after agonist administration. BDNF single-nucleotide polymorphisms (SNPs) rs12291186, rs6265 and rs7124442 were also genotyped. RESULTS: In the Pima cohort, no significant differences in serum BDNF was observed for 43 LOF subjects versus 65 LOF-matched controls (age, sex and BMI matched; P=0.29) or 20 GOF subjects versus 20 GOF-matched controls (P=0.40). Serum BDNF was significantly associated with genotype for BDNF rs12291186 (P=0.006) and rs6265 (P=0.009), but not rs7124442 (P=0.99); BDNF SNPs did not interact with MC4R status to predict serum BDNF. In the Hispanic cohort, plasma BDNF was not significantly different among 21 LOF subjects, 20 GOF subjects and 28 controls (P=0.79); plasma BDNF was not predicted by BDNF genotype or BDNF-x-MC4R genotype interaction. CONCLUSIONS: Circulating BDNF concentrations were not significantly associated with MC4R functional status, suggesting that peripheral BDNF does not directly reflect hypothalamic BDNF secretion and/or that MC4R signaling is not a significant regulator of the bulk of BDNF expression in humans.
Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Hispanic or Latino , Hypothalamus/metabolism , Indians, North American , Obesity/metabolism , Polymorphism, Single Nucleotide , Receptor, Melanocortin, Type 4/metabolism , Adolescent , Adult , Arizona , Brain-Derived Neurotrophic Factor/blood , Brain-Derived Neurotrophic Factor/genetics , Child , Child, Preschool , Cohort Studies , Female , Genetic Predisposition to Disease , Genotype , Hispanic or Latino/genetics , Hispanic or Latino/statistics & numerical data , Humans , Indians, North American/genetics , Indians, North American/statistics & numerical data , Longitudinal Studies , Male , Mutation , Obesity/ethnology , Obesity/genetics , Promoter Regions, Genetic , Receptor, Melanocortin, Type 4/blood , Receptor, Melanocortin, Type 4/geneticsABSTRACT
Paeonol (2'-hydroxy-4'-methoxyacetophenone), the main active compound of the radix of Paeonia suffruticosa, has been reported to have a beneficial effect in prevention and treatment of cardiovascular diseases. Vascular cell adhesion molecule-1 (VCAM-1), plays a crucial role in case of early inflammatory responses, including atherosclerosis. In this study, we investigated the effect of paeonol on TNF-alpha-induced VCAM-1 expression in rat aortic endothelial cells (RAECs). The VCAM-1 expression in paeonol treated RAECs was measured. Paeonol inhibited TNF-alpha-induced VCAM-1 expression in a concentration-dependent manner. TNF-alpha induced p38 and extracellular signal-regulated kinase 1/2 (ERK1/2) activities that contributed to VCAM-1expression was obviously attenuated after pre-treating RAECs with paeonol. The decrease of VCAM-1 expression by paeonol pretreatment led to a reduction of monocytes adhesion to RAECs. Taken together, our results demonstrated that paeonol inhibited VCAM-1 expression by the attenuation of p38 and ERK1/2 signal transduction pathways. We concluded that paeonol had the potential therapeutic development for use in anti-inflammatory and vascular disorders.
Subject(s)
Acetophenones/pharmacology , Endothelial Cells/drug effects , Monocytes/drug effects , Plant Extracts/pharmacology , Vascular Cell Adhesion Molecule-1/metabolism , Animals , Cell Adhesion/drug effects , Cells, Cultured , MAP Kinase Signaling System/drug effects , Paeonia , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alphaABSTRACT
OBJECTIVE: To study material bases on the antifebirle and hypotensive effect of Flos Chrysanthemi. METHODS: Temperature and blood pressure of rats were measured after treatment by taking several kinds of extracts of Flos Chrysanthemi. RESULTS: After volatile oil of Flos Chrysanthemi (0.8 ml/Kg) was taken by oral administration, temperature on the fever heat of rats could be decreased distinctly. After total flavonid of Flos Chrysanthemi (57 mg/Kg) was injected, blood pressure on rats could be reduced remarkly. CONCLUSION: Volatile oil of Flos Chrysanthemi has antifebrile effect and total flavonid of Flos Chrysanthemi has hypotensive effect, which are one of the Pharmacological bases of dispelling the wind-evil, clearing away the heat-evil, calming the liver, sharping eyes of Flos Chrysanthemi.
Subject(s)
Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Chrysanthemum/chemistry , Fever/drug therapy , Oils, Volatile/pharmacology , Plant Extracts/pharmacology , Animals , Male , Rats , Rats, Wistar , Time FactorsABSTRACT
OBJECTIVE: To observe the effects of paeonol(Pae) on lipid peroxidational reaction and oxidational decorate of low density lipoprotein(LDL). METHOD: The rat model of hyperlipidaemia was established by feeding high lipid diet with cholesterol for 6 weeks. The contents of malondialdehyde(MDA) and oxidized low density lipoprotein(OX-LDL) were measured by thiobarbituric acid reactive substance(TBA) method and sandwich method of enzyme-linked immunosorbent assay for detection of polyclone antibody. LDL of serum in healthy person was separated by improve precipitate method. RESULTS: Pae(300, 150 mg.kg-1) could reduce significantly the levels of MDA of serum, aorta and liver; Pae(300 mg.kg-1) decreased obviously the content of OX-LDL of plasma; Pae(1,000, 200, 40 micrograms.ml-1) refrained markedly the course of oxidational decorate of LDL of serum in healthy person. CONCLUSION: Pae could reduce the levels of MDA and OX-LDL in hyperlipidaemia rats, and refrain the oxidational decorates of LDL of serum in healthy person.
Subject(s)
Acetophenones/pharmacology , Hyperlipidemias/metabolism , Lipoproteins, LDL/blood , Acetophenones/isolation & purification , Animals , Aorta/metabolism , Humans , Lipid Peroxidation/drug effects , Liver/metabolism , Male , Oxidation-Reduction , Paeonia/chemistry , Plants, Medicinal/chemistry , Random Allocation , Rats , Rats, WistarABSTRACT
OBJECTIVE: To study the effect of paeonol on experimental atherosclerosis in quails caused by high lipid feeding. METHOD: The effects of oral administration of 300 and 600 mg/kg of paeonol on lipid levels in serum, hemorrheology and aortic intimal abnormalities were investigated. RESULT: Paeonol decreased TC, TG, LDL, vLDL, APOB100 levels in serum and TC levels in aorta and liver. The ratios of HDL/TC, HDL2/HDL3, apoA1/apoB100 were elevated. In addition, the drug reduced the whole blood viscosity, Plasma viscosity and plasma fibrinogen, and inhibited erythrocyte aggregation. CONCLUSION: Oral administration of paeonol can reduce the development of atherosclerosis.
Subject(s)
Acetophenones/pharmacology , Arteriosclerosis/blood , Drugs, Chinese Herbal/pharmacology , Acetophenones/isolation & purification , Animals , Aorta/pathology , Apolipoprotein B-100 , Apolipoproteins B/blood , Arteriosclerosis/etiology , Arteriosclerosis/pathology , Lipoproteins, LDL/blood , Male , Paeonia/chemistry , Plants, Medicinal/chemistry , Quail , Triglycerides/bloodABSTRACT
The principal inhibitory neurotransmitter GABA (gamma-aminobutyric acid) exerts its effects through two ligand-gated channels, GABA(A) and GABA(C) receptors, and a third receptor, GABA(B) , which acts through G proteins to regulate potassium and calcium channels. Cells heterologously expressing the cloned DNA encoding the GABA(B)R1 protein exhibit high-affinity antagonist-binding sites, but they produce little of the functional activity expected from studies of endogenous GABA(B) receptors in the brain. Here we describe a new member of the GABA(B) polypeptide family, GABA(B)R2, that shows sequence homology to GABA(B)R1. Neither GABA(B)R1 nor GABA(B)R2, when expressed individually, activates GIRK-type potassium channels; however, the combination of GABA(B)R1 and GABA(B)R2 confers robust stimulation of channel activity. Both genes are co-expressed in individual neurons, and both proteins co-localize in transfected cells. Moreover, immunoprecipitation experiments indicate that the two polypeptides associate with each other, probably as heterodimers. Several G-protein-coupled receptors (GPCRs) exist as high-molecular-weight species, consistent with the formation of dimers by these receptors, but the relevance of these species for the functioning of GPCRs has not been established. We have now shown that co-expression of two GPCR structures, GABA(B)R1 and GABA(B)R2, belonging to the same subfamily is essential for signal transduction by GABA(B) receptors.
Subject(s)
Receptors, GABA-B/metabolism , Receptors, GABA , Amino Acid Sequence , Animals , Blotting, Western , CHO Cells , COS Cells , Cell Line , Cricetinae , GABA-B Receptor Agonists , GABA-B Receptor Antagonists , Hypothalamus/metabolism , Male , Molecular Sequence Data , Mutation , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, GABA-B/genetics , Transfection , XenopusABSTRACT
The Chinese Bone Extract Granules could enhance the immunity of mice with spleen-deficiency, increase the serum calcium content of rats with bone loose, inhibit the gastrointestinal movement of mice with spleen-deficiency and improve the absorption of D-xylose in small intestine of rats with spleen-deficiency. The maximal tolerance dose for mice to take orally twice a day was greater than 50 g/kg. The subacute toxicologic test for 6 weeks of continuous feeding to rats did not show any obvious toxicity.
Subject(s)
Materia Medica/pharmacology , Osteoporosis/metabolism , Yang Deficiency/immunology , Animals , Calcium/metabolism , Female , Gastrointestinal Motility/drug effects , Hypersensitivity, Delayed/drug therapy , Intestinal Absorption/drug effects , Male , Materia Medica/toxicity , Mice , Rats , Xylose/metabolism , Yang Deficiency/physiopathologyABSTRACT
The present study has shown that Guizhi Decoction can increase the normal myocardial blood flow in rabbits. The best result can be achieved in twenty minutes after the decoction is given (ig).